Robert Duchscher Sells 50,000 Shares of SunOpta Inc. (NASDAQ:STKL) Stock

SunOpta Inc. (NASDAQ:STKLGet Free Report) (TSE:SOY) insider Robert Duchscher sold 50,000 shares of SunOpta stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $7.33, for a total value of $366,500.00. Following the transaction, the insider now directly owns 42,971 shares in the company, valued at approximately $314,977.43. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

SunOpta Trading Down 2.1 %

Shares of NASDAQ:STKL opened at $7.29 on Friday. The company has a quick ratio of 0.61, a current ratio of 1.20 and a debt-to-equity ratio of 1.61. The business has a 50-day moving average of $6.33 and a two-hundred day moving average of $5.89. SunOpta Inc. has a fifty-two week low of $3.85 and a fifty-two week high of $7.59.

SunOpta (NASDAQ:STKLGet Free Report) (TSE:SOY) last announced its earnings results on Tuesday, November 5th. The company reported $0.02 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.02. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. The firm had revenue of $176.22 million during the quarter, compared to analysts’ expectations of $172.30 million. On average, research analysts anticipate that SunOpta Inc. will post 0.13 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages recently commented on STKL. StockNews.com raised shares of SunOpta from a “sell” rating to a “hold” rating in a research report on Saturday. DA Davidson reaffirmed a “buy” rating and issued a $9.00 price target on shares of SunOpta in a research note on Thursday, October 10th. Finally, Stephens increased their price objective on SunOpta from $9.00 to $10.00 and gave the stock an “overweight” rating in a report on Wednesday. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $9.50.

Read Our Latest Report on STKL

Hedge Funds Weigh In On SunOpta

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC bought a new position in shares of SunOpta during the 3rd quarter worth about $6,394,000. Blair William & Co. IL lifted its position in shares of SunOpta by 77.0% in the 1st quarter. Blair William & Co. IL now owns 1,971,345 shares of the company’s stock worth $13,543,000 after acquiring an additional 857,603 shares during the period. Marshall Wace LLP grew its holdings in shares of SunOpta by 116.3% during the 2nd quarter. Marshall Wace LLP now owns 1,396,724 shares of the company’s stock worth $7,542,000 after purchasing an additional 751,126 shares in the last quarter. Harbor Capital Advisors Inc. increased its position in shares of SunOpta by 127.6% during the third quarter. Harbor Capital Advisors Inc. now owns 1,063,918 shares of the company’s stock valued at $6,788,000 after purchasing an additional 596,403 shares during the period. Finally, Millennium Management LLC raised its stake in shares of SunOpta by 52.5% in the second quarter. Millennium Management LLC now owns 1,333,948 shares of the company’s stock valued at $7,202,000 after purchasing an additional 459,053 shares in the last quarter. Institutional investors own 85.39% of the company’s stock.

SunOpta Company Profile

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Featured Articles

Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.